loadpatents
Patent applications and USPTO patent grants for Weaver; Donald F..The latest application filed is for "5-(2,5-bis(4-chloro-2-isopropylphenyl)thiophen-3-yl)-1h-tetrazole for the topical treatment of bacterial infections".
Patent | Date |
---|---|
5-(2,5-bis(4-chloro-2-isopropylphenyl)thiophen-3-yl)-1h-tetrazole For The Topical Treatment Of Bacterial Infections App 20200369653 - Wu; Fan ;   et al. | 2020-11-26 |
Methods For Identifying Inhibitors Of Amyloid Protein Aggregation App 20190050526 - Barden; Christopher J. ;   et al. | 2019-02-14 |
Methods For Identifying Inhibitors Of Amyloid Protein Aggregation App 20160283652 - BARDEN; Christopher J. ;   et al. | 2016-09-29 |
Cognitive function assessment in a patient Grant 9,339,227 - D'arcy , et al. May 17, 2 | 2016-05-17 |
Terpene Analogues And Uses Thereof For Treating Neurological Conditions App 20140357725 - Weaver; Donald F. ;   et al. | 2014-12-04 |
Cognitive Function Assessment in a Patient App 20130245422 - D'arcy; Ryan ;   et al. | 2013-09-19 |
Methods of treating amyloid disease using analogs of 1-(4-nitrophenyl) piperazine Grant 8,420,640 - Barden , et al. April 16, 2 | 2013-04-16 |
Compounds and methods for treating protein folding disorders Grant 8,362,066 - Carter , et al. January 29, 2 | 2013-01-29 |
Methods Of Treating Amyloid Disease Using Analogs Of 1-(4-nitrophenyl) Piperazine App 20110218200 - Barden; Christopher J. ;   et al. | 2011-09-08 |
Methods and compounds for inhibiting amyloid deposits Grant 7,786,174 - Szarek , et al. August 31, 2 | 2010-08-31 |
Sulfonated compounds and compositions for treating amyloidosis Grant 7,754,761 - Kisilevsky , et al. July 13, 2 | 2010-07-13 |
Compounds And Methods For Treating Protein Folding Disorders App 20100144821 - Carter; Michael D. ;   et al. | 2010-06-10 |
Method of inhibiting neurotrophin-receptor binding App 20090215814 - Ross; Gregory M. ;   et al. | 2009-08-27 |
Pyrimidine compounds as anti-ictogenic and/or anti-epileptogenic agents Grant 7,501,429 - Weaver , et al. March 10, 2 | 2009-03-10 |
Methods And Compounds For Inhibiting Amyloid Deposits App 20080227767 - Szarek; Walter A. ;   et al. | 2008-09-18 |
Method of inhibiting neurotrophin-receptor binding App 20080221147 - Ross; Gregory M. ;   et al. | 2008-09-11 |
Methods and compounds for inhibiting amyloid deposits Grant 7,393,875 - Szarek , et al. July 1, 2 | 2008-07-01 |
Method of inhibiting neurotrophin-receptor binding App 20070078137 - Ross; Gregory M. ;   et al. | 2007-04-05 |
Diagnostic methods for determining susceptibility to convulsive conditions App 20070042497 - Campbell; Allyson J. ;   et al. | 2007-02-22 |
Treatment of protein folding disorders App 20070015813 - Carter; Michael D. ;   et al. | 2007-01-18 |
Diagnostic methods for determining susceptibility to convulsive conditions Grant 7,153,692 - Campbell , et al. December 26, 2 | 2006-12-26 |
Method of inhibiting neurotrophin-receptor binding Grant 7,148,352 - Ross , et al. December 12, 2 | 2006-12-12 |
Method of inhibiting neurotrophin-receptor binding App 20060063793 - Ross; Gregory M. ;   et al. | 2006-03-23 |
Heterocyclic anti-epileptogenic agents and methods of use thereof App 20060014752 - Weaver; Donald F. ;   et al. | 2006-01-19 |
Diagnostic methods for determining susceptibility to convulsive conditions App 20060008917 - Campbell; Allyson J. ;   et al. | 2006-01-12 |
Anti-epileptogenic agents Grant 6,930,112 - Weaver , et al. August 16, 2 | 2005-08-16 |
Methods and compounds for inhibiting amyloid deposits App 20040248876 - Szarek, Walter A. ;   et al. | 2004-12-09 |
Compositions and methods for treating amyloidosis App 20040198832 - Szarek, Walter A. ;   et al. | 2004-10-07 |
Anti-epileptogenic agents App 20030229144 - Weaver, Donald F. ;   et al. | 2003-12-11 |
Method of inhibiting neurotrophin-receptor binding App 20030203923 - Ross, Gregory M. ;   et al. | 2003-10-30 |
Anti-epileptogenic agents App 20030194375 - Weaver, Donald F. ;   et al. | 2003-10-16 |
Method of inhibiting neurotrophin-receptor binding App 20030186901 - Ross, Gregory M. ;   et al. | 2003-10-02 |
Pyrimidine compounds as anti-ictogenic and/or anti-epileptogenic agents App 20030153584 - Weaver, Donald F. ;   et al. | 2003-08-14 |
Heterocyclic anti-epileptogenic agents and methods of use thereof App 20030114441 - Weaver, Donald F. ;   et al. | 2003-06-19 |
Methods and compounds for inhibiting amyloid deposits Grant 6,562,836 - Szarek , et al. May 13, 2 | 2003-05-13 |
Diagnositc methods for determining susceptibility to convulsive conditions App 20030077833 - Campbell, Allyson J. ;   et al. | 2003-04-24 |
Method of inhibiting neurotrophin-receptor binding Grant 6,492,380 - Ross , et al. December 10, 2 | 2002-12-10 |
Method of enhancing effect of a neurotrophin with analogues of p75NTR367-379. Grant 6,417,159 - Riopelle , et al. July 9, 2 | 2002-07-09 |
Methods of screening for factors that disrupt neurotrophin conformation and reduce neurotrophin biological activity Grant 6,291,247 - Riopelle , et al. September 18, 2 | 2001-09-18 |
Molecular modelling of neurotrophin-receptor binding Grant 6,029,114 - Shamovsky , et al. February 22, 2 | 2000-02-22 |
Liquid Pressure Conditioner Grant 3,734,126 - Weaver May 22, 1 | 1973-05-22 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.